Group 1: Company Announcements - ChaoYing Electronics' wholly-owned subsidiary plans to invest 1.468 billion RMB in an AI computing high-end printed circuit board expansion project in Thailand, aiming to enhance its product layout in high-end PCB applications such as routers and AI servers [1] - DeMingLi is in the process of planning a refinancing matter, which is still in the internal communication stage without a clear plan or determined financing amount [1] - *ST YuanCheng's stock has triggered mandatory delisting due to a market capitalization below 500 million RMB for 20 consecutive trading days, leading to a suspension of trading starting November 11, 2025 [1] Group 2: Investment and Cooperation - ZhongBei Communication signed a framework agreement for comprehensive computing services worth 1 billion RMB with Hongxin Electronics, with a service period of 60 months [2] - ShangTai Technology plans to invest approximately 4.07 billion RMB in a project to produce 200,000 tons of lithium-ion battery anode materials in Shanxi Province [3] Group 3: Clinical Trials and Approvals - Maiwei Bio's innovative drug 9MW3811 injection for pathological scars has received approval for a Phase II clinical trial, with plans to start by the end of 2025, positioning it as the first IL-11 targeted drug in this indication [3]

Core Viewpoint - The announcement from Sanmei Co., Ltd. indicates that the controlling shareholder, Hu Rongda, plans to reduce his stake in the company by selling up to 18,314,370 shares, which represents approximately 3% of the total share capital [1] Group 1: Shareholding Structure - Hu Rongda holds 225,229,140 shares, accounting for approximately 36.89% of the total share capital [1] - His associate, Hu Qixiang, holds 103,738,226 shares, representing about 16.99% of the total share capital [1] - Wuyi Sanmei Investment Co., Ltd. holds 48,937,288 shares, which is about 8.02% of the total share capital [1] - Together, Hu Rongda and his associates hold a total of 377,904,654 shares, amounting to approximately 61.90% of the total share capital [1] Group 2: Planned Share Reduction - Hu Rongda intends to reduce his holdings through centralized bidding and block trading within three months after the announcement [1] - The maximum number of shares to be sold through centralized bidding is limited to 1% of the total share capital within any consecutive 90-day period [1] - The maximum number of shares to be sold through block trading is limited to 2% of the total share capital within any consecutive 90-day period [1]

Summary of Key Points Core Viewpoint - On November 10, several A-share listed companies disclosed their shareholding changes, with some announcing share buybacks while others reported share reductions by major shareholders [1]. Group 1: Share Buybacks - Hangcai Co. proposed to use 50 million to 100 million yuan of surplus funds for share repurchase [2]. - Sunong Bank executives plan to increase their holdings by no less than 1.8 million yuan in A-shares within six months [2]. - Jiangsu Cable's controlling shareholder received loan support for increasing A-share holdings [2]. Group 2: Share Reductions - A total of 25 A-share listed companies announced share reductions, including: - Aojing Medical plans to reduce no more than 0.19% of its shares by directors and executives [2]. - Maipu Medical's shareholder Guoshou Chengda intends to reduce no more than 1% of its shares [2]. - Shoulv Hotel's Ctrip Shanghai reduced 25.206 million shares on November 10 [2]. - Mingchen Health's controlling shareholder plans to reduce no more than 3% of the total share capital [2]. - Meiri Interactive's shareholder "I Got a Push" intends to reduce no more than 1% of its shares [2]. - Qicai Chemical's shareholder Beijing Fengyan plans to reduce no more than 0.98% of its shares [2]. - Other companies with planned reductions include Zhongheng Design, Xin Kaipu, Lianying Laser, Hongxin Electronics, and others, with reductions ranging from 0.07% to 5% [2].

2025年11月11日，浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）发布控股股东减持股份 计划公告，公司控股股东、实际控制人胡荣达拟在未来3个月内通过集中竞价及大宗交易方式减持公司 股份，减持数量不超过1831.44万股，占公司总股本的3%。 登录新浪财经APP 搜索【信披】查看更多考评等级 减持主体及持股基本情况 公告显示，本次减持主体为三美股份控股股东、实际控制人胡荣达。截至公告披露日，胡荣达直接持有 公司股份22522.914万股，占公司总股本的36.8938%；其一致行动人胡淇翔持有10373.8226万股，占总 股本16.9929%；武义三美投资有限公司持有4893.7288万股，占总股本8.0162%。胡荣达及其一致行动人 合计持股37790.4654万股，占公司总股本的61.9030%。 股东名称 持股数量（万股） 持股比例 一致行动关系形成原因 胡荣达 22522.914 36.8938% 胡荣达与胡 淇翔系父子关系；胡荣达、胡淇翔分别持有武义三美投资有限公司60%、30%股权 胡淇翔 10373.8226 16.9929% 武义三美投资有限公司 4893.7288 8.0162 ...

证券代码：603379 证券简称：三美股份 公告编号：2025-073 浙江三美化工股份有限公司 控股股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 重要内容提示： 控股股东持股的基本情况 本次减持主体为浙江三美化工股份有限公司（以下简称"三美股份"或"公 司"）控股股东、实际控制人胡荣达先生。截至本公告披露日，胡荣达先生持有 公司股份 225,229,140 股，约占公司总股本的 36.8938%；其一致行动人胡淇翔先 生持有公司股份 103,738,226 股，约占公司总股本的 16.9929%，武义三美投资有 限公司持有公司股份 48,937,288 股，约占公司总股本的 8.0162%。胡荣达先生及 其一致行动人合计持有公司股份 377,904,654 股，约占公司总股本的 61.9030%。 减持计划的主要内容 自本公告披露之日起 15 个交易日后的 3 个月内，胡荣达先生拟通过集中竞 价交易及大宗交易的方式减持其持有的公司无限售条件流通股不超过 18,314,370 股，约占公司总 ...

格隆汇11月10日丨三美股份(603379.SH)公布，自本公告披露之日起15个交易日后的3个月内，控股股 东、实际控制人胡荣达先生拟通过集中竞价交易及大宗交易的方式减持其持有的公司无限售条件流通股 不超过1831.44万股，约占公司总股本的3%，其中：通过集中竞价交易方式减持的，在任意连续90日内 减持股份的总数不超过公司总股本的1%；通过大宗交易方式减持的，在任意连续90日内减持股份的总 数不超过公司总股本的2%。减持价格按市场价格确定。 ...

人民财讯11月10日电，三美股份（603379）11月10日公告，公司控股股东、实控人胡荣达计划15个交易 日后的3个月内，减持公司无限售条件流通股不超过1831.44万股，约占公司总股本的3%。 ...

每经AI快讯，11月10日，三美股份（603379）(603379.SH)公告称，控股股东胡荣达计划减持不超过 1831.44万股公司股份，约占公司总股本的3%，通过集中竞价交易和大宗交易方式实施，减持期间为 2025年12月3日至2026年3月2日，减持原因为个人资金需求。 ...

三美股份公告，控股股东、实际控制人胡荣达拟减持不超过3%。 ...

南财智讯11月10日电，三美股份公告，公司控股股东、实际控制人胡荣达先生计划自公告披露之日起15 个交易日后的3个月内，通过集中竞价交易及大宗交易方式减持其持有的公司无限售条件流通股不超过 1831万股，约占公司总股本的3%。其中，通过集中竞价交易方式减持的，在任意连续90日内减持股份 总数不超过公司总股本的1%；通过大宗交易方式减持的，在任意连续90日内减持股份总数不超过公司 总股本的2%。减持价格将按市场价格确定，减持原因为个人资金需求。截至公告披露日，胡荣达持有 公司股份225,229,140股，约占公司总股本的36.89%。 ...